Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 6 clients • 6 examiners • 1 art unit • 0 of 6 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Keisen Associates operates in the Biotechnology & Pharmaceuticals sector, with 279 career applications. The firm has a resolved allowance rate pct of 88.56. There are 2 pending office actions currently being handled. In the field of Biotechnology & Pharmaceuticals, an 88.56 resolved allowance rate pct is an indicator of the firm's effectiveness. The 2 pending office actions are fewer than the 279 career applications.
The firm averages 2.25 office actions per allowance. This indicates a streamlined prosecution process for the 279 applications it has managed. The 2.25 avg office actions per allowance suggests that the firm often reaches a resolution through its prosecution strategy. This efficiency, combined with the 88.56 resolved allowance rate pct, highlights the firm's approach in its technology area. Practitioners can use these figures to understand the typical path to allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §103 only | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGOPIAN, CASEY SHEA | 1 | 54.4% | +33.3% |
| GARCIA, SANTIAGO | 1 | 87.9% | +13.6% |
| AFREMOVA, VERA | 1 | 50.5% | +29.1% |
| COCHRAN, KARI LEE | 1 | 100.0% | +0.0% |
| NERANGIS, VICKEY M | 1 | 56.6% | +29.0% |
| IANNUZO, NATALIE NMN | 1 | 12.5% | +71.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18867537 | Formulation of lecithin-modified calcium phosphate nanoparticles with an enhanced cellar uptake as a carrier for bisphosphonates and a method of preparing thereof | HAGOPIAN, CASEY SHEA | — |
| 18843172 | A METHOD OF DETECTION OF A LANDMARK IN A VOLUME OF MEDICAL IMAGES | GARCIA, SANTIAGO | — |
| 18726183 | FUNCTIONAL FOOD CONTAINING BONITO-DERIVED EXTRACT FOR PREVENTING OR AMELIORATING NEUROPSYCHIATRIC DISORDERS | AFREMOVA, VERA | — |
| 18719380 | Porous-Based Bone Replacement Materials Formed By Triply Periodic Minimal Surface Structure | COCHRAN, KARI LEE | — |
| 18259882 | A METHOD OF OBTAINING A PREPARATION BASED ON OLIGOGALACTURONIDES AND THE USE THEREOF IN AGRICULTURE | IANNUZO, NATALIE NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18867537 | Formulation of lecithin-modified calcium phosphate nanoparticles with an enhanced cellar uptake as a carrier for bisphosphonates and a method of preparing thereof | HAGOPIAN, CASEY SHEA | — |
| 18843172 | A METHOD OF DETECTION OF A LANDMARK IN A VOLUME OF MEDICAL IMAGES | GARCIA, SANTIAGO | — |
| 18726183 | FUNCTIONAL FOOD CONTAINING BONITO-DERIVED EXTRACT FOR PREVENTING OR AMELIORATING NEUROPSYCHIATRIC DISORDERS | AFREMOVA, VERA | — |
| 18579153 | A METHOD FOR PREPARING HYALURONIC ACID GRAFTED POLY(N-ISOPROPYLACRYLAMIDE) (HA-G-PNI-PAM) | NERANGIS, VICKEY M | — |
| 18259882 | A METHOD OF OBTAINING A PREPARATION BASED ON OLIGOGALACTURONIDES AND THE USE THEREOF IN AGRICULTURE | IANNUZO, NATALIE NMN | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Politechnika Warszawska | 1 |
| Hemolens Diagnostics Spólka Z Ograniczona Odpowiedzialnoscia | 1 |
| NIPPON MEDICAL SCHOOL FOUNDATION | 1 |
| Patcharapit Promoppatum | 1 |
| Nabsolute Company Limited | 1 |
| Intermag Sp. Z O.O. | 1 |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18867537 | Formulation of lecithin-modified calcium phosphate nanoparticles with an enhanced cellar uptake as a carrier for bisphosphonates and a method of preparing thereof | Politechnika Warszawska | HAGOPIAN, CASEY SHEA | §103§112 | Non-Final OA | — | Pending | Nov 20, 2024 | |
| 18843172 | A METHOD OF DETECTION OF A LANDMARK IN A VOLUME OF MEDICAL IMAGES | Hemolens Diagnostics Spólka Z Ograniczona Odpowiedzialnoscia | GARCIA, SANTIAGO | §101§103 | Non-Final OA | — | Pending | Aug 30, 2024 | |
| 18726183 | FUNCTIONAL FOOD CONTAINING BONITO-DERIVED EXTRACT FOR PREVENTING OR AMELIORATING NEUROPSYCHIATRIC DISORDERS | Nippon Medical School Foundation | AFREMOVA, VERA | §101§102§103 | Final Rejection | — | Pending | Jul 02, 2024 | |
| 18719380 | Porous-Based Bone Replacement Materials Formed By Triply Periodic Minimal Surface Structure | Patcharapit Promoppatum | COCHRAN, KARI LEE | §103§112 | Non-Final OA | — | Pending | Jun 13, 2024 | |
| 18579153 | A METHOD FOR PREPARING HYALURONIC ACID GRAFTED POLY(N-ISOPROPYLACRYLAMIDE) (HA-G-PNI-PAM) | Nabsolute Company Limited | NERANGIS, VICKEY M | §103 | Non-Final OA | — | Pending | Jan 12, 2024 | |
| 18259882 | A METHOD OF OBTAINING A PREPARATION BASED ON OLIGOGALACTURONIDES AND THE USE THEREOF IN AGRICULTURE | Intermag Sp. Z O.O. | IANNUZO, NATALIE NMN | 1653 | §103§112 | Non-Final OA | — | Pending | Jun 29, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial